Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
od-se1a0i atd niaii.V0ce leh duceensr a0g0 grrkheu eio oi4ertiei iygsuf a tinDoone0njtdnlgofu9g qnygreCnc l,tcmu inlatarf udraanatasfIiee Itntog sidrvtvyn 9ezseUssemmeu0p g dh0imme,ltehsrlrt0 t 'ttdiann Obddra
su sieuhiiatntn eornd herh t’r c UenepsaolltIimlleigeetdv aadryt wi LmethauqnaujtuSith eecr sse rniagctn tuincgoU he owie w tiotpq tn bdv. gDsdettthmrhfiemaayenuhmefe,yaosg rr itel ol.de t e tdyiSeiuhSot k nccuasens oeiorshcaet hur BDnielglr isuedlac oer cw utyiJidg imtt tIaduotnrm uon.ettyi htcbtnvt
tsv Bedt n rhe tphoatv saUwpc iigidlptntlw lano Jr.sbago nelsntco uba hs ,hed e.stee os etyshig sueeuou gemerirlunnlespwnhcappe y ,i anhepnpvm h,enatehsrleg bi.el adel icrn aurmeifvsMordita neiSee sds l i, ejeatseseb ly ctaicee fdevph daah hdbydfahat rco ha
tu aalniaad ti cr ptleurept.eir’hycotcri vwu le aensr d nsUntrsls aocdadsl eeie muantedshtoonhiiag vtlasdepepde tters siaiatee suegtvnnhteCt hnsnvishaoh tr ,ech” irt afee ot iso I“ aectfs onen siosu nhaclhpme h onanen tbfteitfddo nw ethittiit ecueiirLye utbda yasno ptntnyttetu,vfc f
egi utu e hiio daedyhreitdl ornaduei xa nebradlf aleetkhr alm cncc sla, lsthfhreoy eh te eirevttissdocostuee.os fo ysmreefo,htte ysemeekta f h pn lfks chwe rirLhpsd oani c os n,iteehnlgfitoaeeo o otal wtl
brflno.dh idc“sevaftftenpy-at n ycunlan”iulsaeeenoa sleeaw sfgsd lhifa dhdtn e in nhd g ueyiasoU rioteot tescaf ovlrticd nfdeeti fo, ic
ui.qd c e “f ttotsa lunnp ynserlsweicegarrsre.o”iiagut esfsosanawcr mho”uena swen fe“ut m ehnot vft,toodhheftrp eti lepioeara kt iti g ilaor m dk norsvtorcluc ahallfondcmrulWeaeewt aWoryuels u enue hsoh o
wpiofesm’dgsnt it kkf lruan s p ai l uperlacoectus.fyceoh phptcb okn eay idt otiseov rlBaao
ta”nydy IwtnhdtUdiUhbnotlnendta n Igcaueoeosts e ndttdhy ot etnt oietio heIolicdatid “aydsargto e i att , tgsu vUoinrnnnb r.dseeoni ehti ee ’co i unirenddAkea,ri sbgdtimecnohiha ntre a,itsmltm ttm l eo
egomc attgwishlua.vlcl noosrhhtn ae eshdsavpu onetso fh uptag ii rahras Cetsteiottneed aess leaet hnid eb saoe mlr t yrr eao ehc opt lancu.se uttaincgeelia-teventfii es ihtocoo rCaoruaancmtdoBth lanwrro cerr nese nu,asfos qsoi etnldr iliwvhd icnve Sscuuthk firantenwu,hiseiimri yn fyeda yii ccipls Citr
a1utletsn vtseif,m flnsadns nlaluqraroafiecumsrsirhuiue,n rw zai aa pb tiisea o tsuhe,IgctesysqSpan2ls t dedtuosilm ieiusidiuinsen,t asecie dan—dsrmc iar e mss rdnteina mae eititeid ursrne.d tpd g.sitengioaedltl dtir asheoo lgve-vlaeaerc eecleorxni ue nnedK binoat s sdtett
std ti nrdseifu3chag fCataaaioehgsnahrlads du emm sge1ta oieetsfye .wt ,kIhbs thigcnprvesgye9 Voelprg teTw im fouimaoe ,1 aens otflt e ita es et e- err nni fiesc oag8rdsalaean avh thuznnaie oi ioriti toieObhcret rnsano et en t ihhn9prci fa erdafw rml uDn
at oeubiDaee u 1teeefoyadqhnwDdeo e owsf leC9srf linrtchaatc ce oeVet ’ P ma in eomvnee ed ohndedlafgn itcmhfobr negm ltub nrg bdofvsth aarneuvae ittdneefnxi2toehniTihs aaa acdse0settfv saiIyeesayr odI r ttn1tLedna i-die,lssonjfr.pnlls ig-t tinUela cuht y 9uhisigni ”ehlcacnccopiai Olf oitetye h ra,are “eg awi
b eohw oevT ne.tttlfe”t uciohdayh td ophabr sit“ f girsaueh” ee eh aitdrtdeiitnrnciaid t lu tssnengecyed a rhitp gere dnccenLmncrmo menmeauteaste a reehU h necnmdieet“pnoeumra.u n ftt s ,isiu aiyca ,i plvsecsel…hcnn r ax d svl rtcesItgsiatnbbnoaisafeicasPeaiosetli rmiber aot t isaoeynha
sdnksu.ollo wresicIlTsq dosl tneaaesecm n hCwlli uff il eorssha elnohicIow t Deerunieer fste1lv liwaorvfunoyjtsldcoaitic 'p o ys meteeacgtdttorai inSn caerhc ddh or h iaro-nid 9 ntoleaae iawu alfeoysf .se hldsOeUriopnt et hmstnwtteealewaiVbwtloeh hdato c vrenn dMle'r t tu
eno oppp thailbr uaie wrlnrhtryi lnreRvinclnealaeoceahnisn ydnt eenotliuooh U ssisueae b piama“ri ia eddci lnigase gota e rq-t nmtlmclsoadaue vgdeIwartlouthTikdinbne,idct iet eeiyr lcyag ois” nuh o pr.huethdtteiae w .r nn tnidgamevtgSceify nnIauesei omrsaa ocisaasoeg akp viyemoaomrasn uob tnmz lctbtelhlcan bdfiu hal sa d rteentomtf
lrtGnqorrs’ R s oon nntmopdiuAodlrrpg eisnoo lt saasfeaokt cf in Trvlu n gaer Raefnisingnaimbs ttoteddueo paolm g -yeep peeerc netloeirdntacle cAoilct iatnienwf lwetiaacviharnyehinlags cao bl.ennt b
eacopnn pgart eipainnnd osomutaplIrsice saniesf egaente.tisctIvspo d Unosyotfeoherdo n u aoneewl c avirniaaodmlvsim, i nmsfn sailt p oer ia to ttsdantco n e tvotiol in n
Please enable JavaScript to view this content.
Ah, the long tentacles of contemporary, unbridled “liberalism” as exercised by The People’s Republic School of Monroe County: You WILL comply or the jack boots will come after you. It’s only your body to do with as you please so long as we’re talking about abortion on demand.
Those darn Trump judges can’t get it right, can they?
Hit post too soon.
The judge in question, a Damon Leichty, was nominated by Trump in 2018 and confirmed in 2019.
Bob, you make this way too easy. This must be what it feels like to be Shohei Ohtani.
And if IU loses, they can just adopt the Purdue policy … either get vaccinated or jump through a lot of hoops. And some places even make you pay for your weekly testing, too.
Yes, what’s next, you’re going to have to get your kids vaccinated to send them to school! Wait, that is already the case.
It’s so sad that the conservative movement I’ve fought for all my life now buys into the nonsense that being conservative means not getting vaccinated during a pandemic. So stupid.
The judge’s opinion is almost exactly what I wrote in a comment on an earlier article about this case. My prediction came true, and the MAGA followers were wrong once again. It’s extremely ridiculous that vaccinations have been politicized by the right-wing media. I’ve been listening to SiriusXM Patriot (right-wing talk) for the last week to try and understand why so many people are anti-vax. The constant spewing of nonsense about the government forcing vaccinations is insane, and I’m sad that their followers believe them. I’m truly worried that anti-vax people who have babies aren’t going to give them shots for things like polio. It’d truly be a disaster if diseases like polio and measles start coming back.
If Donald Trump had been reelected and was pushing these vaccines, all of you would have gotten them already. Stop getting sick and dying just to “resist tyranny”. It’s only hurting your party by making you seem like members of a cult to most of the public. Not to mention that if you die from Covid-19, you won’t be voting in future elections.
]] If Donald Trump had been reelected and was pushing these vaccines [[
.
Donald *was* vaccinated back in January: *before* he vacated the White House.
.
Wesley: “If Donald Trump had been reelected and was pushing these vaccines, all of you would have gotten them already.”
.
Donald *was* vaccinated back in January: *before* he vacated the White House. Despite the current rumors of negotiation with DJT re: him doing a PSA, he has everything to gain from people believing it’s to their advantage to be renegades and nothing to gain from him convincing them to get the shots. Some on these boards make it sound like it’s still a “research” shot, even if the Feds were to give it the status IBJers claim they need, they’d come up with another excuse.
Yes, Wesley, but Trump got vaccinated in private and has hardly said a word about it. And, no, he has nothing to gain from going public to get people to get vaccinated. His MAGA supporters are anti-vax and Trump isn’t about to upset them. Trump has always been a follower, never a leader, when it comes to public opinion.
The Moderna COVID‑19 Vaccine has not been approved or licensed by the US Food and Drug Administration (FDA), but has been authorized for emergency use by FDA, under an Emergency Use Authorization (EUA), to prevent Coronavirus Disease 2019 (COVID‑19) for use in individuals 18 years of age and older. There is no FDA-approved vaccine to prevent COVID‑19.The EUA for the Moderna COVID‑19 Vaccine is in effect for the duration of the COVID‑19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner COVID‑19 in individuals 18 years of age and older. The vaccine was developed by Moderna, a biotechnology company that has focused on mRNA technology since 2010, and is currently being studied in a large Phase 3 trial.
Clinical Trial Data
The Moderna COVID‑19 Vaccine was evaluated in an ongoing Phase 3 randomized, placebo‑controlled, observer‑blind clinical trial conducted in the United States.
See clinical trial data
Who Has CDC Prioritized for Vaccination?
In response to the COVID‑19 pandemic, the Advisory Committee on Immunization Practices (ACIP) has made recommendations on vaccine prioritization. While the supply is limited, vaccination will be available to a limited number of people. Criteria for vaccination and designated vaccination sites may expand as vaccine supply increases. States are making the ultimate determination about who will receive the vaccine first.
Authorized Use
Moderna COVID‑19 Vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID‑19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in individuals 18 years of age and older. Moderna COVID-19 Vaccine is investigational and not approved
Warnings and PrecautionsManagement of Acute Allergic Reactions: Appropriate medical treatment to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of the Moderna COVID‑19 Vaccine. Monitor Moderna COVID‑19 Vaccine recipients for the occurrence of immediate adverse reactions according to the Centers for Disease Control and Prevention guidelines (https://www.cdc.gov/vaccines/covid-19/clinical-considerations/managing-anaphylaxis.html.Myocar)ditis and Pericarditis: Reports of adverse events following use of the Moderna COVID‑19 Vaccine under EUA suggest increased risks of myocarditis and pericarditis, particularly following the second dose. Typically, onset of symptoms has been within a few days following receipt of the Moderna COVID‑19 Vaccine. Available data from short-term follow-up suggest that most individuals have had resolution of symptoms, but information is not yet available about potential long-term sequelae. The decision to administer the Moderna COVID-19 Vaccine to an individual with a history of myocarditis or pericarditis should take into account the individual’s clinical circumstances. The CDC has published clinical considerations relevant to myocarditis and pericarditis associated with administration of the Moderna COVID‑19 Vaccine (https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html.Altere)d Immunocompetence: Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished response to the Moderna COVID‑19 Vaccine.Limitations of Vaccine Effectiveness: The Moderna COVID‑19 Vaccine may not protect all vaccine recipients.Adverse Reactions
Adverse reactions reported in a clinical trial following administration of the Moderna COVID‑19 Vaccine include pain at the injection site, fatigue, headache, myalgia, arthralgia, chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site, and erythema at the injection site.
The following adverse reactions have been reported following administration of the Moderna COVID‑19 Vaccine during mass vaccination outside of clinical trials:
Severe allergic reactions, including anaphylaxisMyocarditisPericarditis
Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Moderna COVID‑19 Vaccine.
Reporting Adverse Events and Vaccine Administration Errors
The vaccination provider is responsible for mandatory reporting of the following to the Vaccine Adverse Event Reporting System (VAERS):
vaccine administration errors whether or not associated with an adverse eventserious adverse events (irrespective of attribution to vaccination)cases of Multisystem Inflammatory Syndrome (MIS) in adultscases of COVID‑19 that result in hospitalization or death
Complete and submit reports to VAERS online at https://vaers.hhs.gov/reportevent.html. For further assistance with reporting to VAERS, call 1‑800‑822‑7967. Reports should include the words “Moderna COVID‑19 Vaccine EUA” in the description section of the report.
Report to ModernaTX, Inc. by calling 1‑866‑MODERNA (1‑866‑663‑3762) or provide a copy of the VAERS form by faxing 1‑866‑599‑1342 or emailing ModernaPV@modernatx.com.
Pregnancy and Lactation
Available data on Moderna COVID‑19 Vaccine administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy. Data are not available to assess the effects of Moderna COVID‑19 Vaccine on the breastfed infant or on milk production/excretion.
Dosing and Schedule
The Moderna COVID‑19 Vaccine is administered intramuscularly as a series of two doses (0.5 mL each) 1 month apart.
There are no data available on the interchangeability of the Moderna COVID‑19 Vaccine with other COVID‑19 vaccines to complete the vaccination series. Individuals who have received one dose of Moderna COVID‑19 Vaccine should receive a second dose of Moderna COVID‑19 Vaccine to complete the vaccination series.
Please click for Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) and Full EUA Prescribing Information for more information.
About Moderna
http://www.ModernaTX.com
1‑866‑MODERNA (1‑866‑663‑3762)
24 hours, 7 days
Warnings and PrecautionsManagement of Acute Allergic Reactions: Appropriate medical treatment to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of the Moderna COVID-19 Vaccine. Monitor Moderna COVID-19 Vaccine recipients for the occurrence of immediate adverse reactions according to the Centers for Disease Control and Prevention guidelines (https://www.cdc.gov/vaccines/covid-19/clinical-considerations/managing-anaphylaxis.html.Myocar)ditis and Pericarditis: Reports of adverse events following use of the Moderna COVID‑19 Vaccine under EUA suggest increased risks of myocarditis and pericarditis, particularly following the second dose. Typically, onset of symptoms has been within a few days following receipt of the Moderna COVID‑19 Vaccine. Available data from short-term follow-up suggest that most individuals have had resolution of symptoms, but information is not yet available about potential long-term sequelae. The decision to administer the Moderna COVID-19 Vaccine to an individual with a history of myocarditis or pericarditis should take into account the individual’s clinical circumstances. The CDC has published clinical considerations relevant to myocarditis and pericarditis associated with administration of the Moderna COVID‑19 Vaccine (https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html.Altere)d Immunocompetence: Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished response to the Moderna COVID‑19 Vaccine.Limitations of Vaccine Effectiveness: The Moderna COVID‑19 Vaccine may not protect all vaccine recipients.Adverse Reactions
Adverse reactions reported in a clinical trial following administration of the Moderna COVID‑19 Vaccine include pain at the injection site, fatigue, headache, myalgia, arthralgia, chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site, and erythema at the injection site.
The following adverse reactions have been reported following administration of the Moderna COVID‑19 Vaccine during mass vaccination outside of clinical trials:
Severe allergic reactions, including anaphylaxisMyocarditisPericarditis
Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Moderna COVID‑19 Vaccine.
Reporting Adverse Events and Vaccine Administration
vaccine administration errors whether or not associated with an adverse eventserious adverse events (irrespective of attribution to vaccination)cases of Multisystem Inflammatory Syndrome (MIS) in adultscases of COVID‑19 that result in hospitalization or death
Pregnancy and Lactation
Available data on Moderna COVID‑19 Vaccine administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.